CD8A and neoplasm: When combined with a serum albumin-binding peptide, DSP, to form DSPOGS, this chimeric peptide significantly enhances the infiltration of CD8+ T cells, leading to effective anti-tumor effects when used alone or in combination with radiotherapy (46).